These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27866147)

  • 1. Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration.
    Rojas-Fernandez CH; Tyber K
    Ann Pharmacother; 2017 Mar; 51(3):264-270. PubMed ID: 27866147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
    Awh CC; Lane AM; Hawken S; Zanke B; Kim IK
    Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
    Chew EY; Klein ML; Clemons TE; Agrón E; Ratnapriya R; Edwards AO; Fritsche LG; Swaroop A; Abecasis GR;
    Ophthalmology; 2014 Nov; 121(11):2173-80. PubMed ID: 24974817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.
    Klein ML; Francis PJ; Rosner B; Reynolds R; Hamon SC; Schultz DW; Ott J; Seddon JM
    Ophthalmology; 2008 Jun; 115(6):1019-25. PubMed ID: 18423869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.
    Awh CC; Hawken S; Zanke BW
    Ophthalmology; 2015 Jan; 122(1):162-9. PubMed ID: 25200399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.
    Assel MJ; Li F; Wang Y; Allen AS; Baggerly KA; Vickers AJ
    Ophthalmology; 2018 Mar; 125(3):391-397. PubMed ID: 29032853
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Vavvas DG; Small KW; Awh CC; Zanke BW; Tibshirani RJ; Kustra R
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E696-E704. PubMed ID: 29311295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis.
    Seddon JM; Silver RE; Rosner B
    Br J Ophthalmol; 2016 Dec; 100(12):1731-1737. PubMed ID: 27471039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFH and ARMS2 Polymorphisms Interact with Zinc Supplements in Cognitive Impairment in the Women's Health Initiative Hormone Trial.
    Kustra R; Awh CC; Rojas-Fernandez C; Zanke B
    J Alzheimers Dis; 2018; 66(2):707-715. PubMed ID: 30320589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000254. PubMed ID: 23152201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Myers CE; Meuer SM; Gangnon RE; Sivakumaran TA; Iyengar SK; Lee KE; Klein BE
    JAMA Ophthalmol; 2013 Mar; 131(3):383-92. PubMed ID: 23494043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of nutritional supplements in treating Age-Related Macular Degeneration: a review of the literature.
    Mukhtar S; Ambati BK
    Int Ophthalmol; 2019 Dec; 39(12):2975-2983. PubMed ID: 31313070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
    Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI
    Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.
    Merle BM; Richard F; Benlian P; Puche N; Delcourt C; Souied EH
    PLoS One; 2015; 10(7):e0130816. PubMed ID: 26132079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.
    Ersoy L; Schick T; de Graft D; Felsch M; Hoyng CB; den Hollander AI; Kirchhof B; Fauser S; Liakopoulos S
    Br J Ophthalmol; 2016 Aug; 100(8):1047-51. PubMed ID: 26614632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
    Loane E; Nolan JM; McKay GJ; Beatty S
    Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.